InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,175.20
(
1.14%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.20
(
-1.26%
)
Bitcoin
61,992.11
(
2.87%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

idcc2006

Send PM Follow Ignore
Followers 3
Posts 1891
Boards Moderated 0
Alias Born 11/28/2005

idcc2006

Re: None

Wednesday, 08/23/2017 1:00:42 AM

Wednesday, August 23, 2017 1:00:42 AM

Post# of 30990
Was there official report after the phase 1 trial? I vaguely remember, I could be wrong, things like no toxicity problem with anatabine, lowering effect of some inflammatory molecule (probably TNF-alpha??), but failure in establishing the effect on NF-kB level due to experimental mistake. Want to read the report if there is.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up